IISc’s potent molecules show promise for TB therapy

Scientists at the Indian Institute of Science (IISc) Bengaluru have developed two new, potent molecules that can severely impact the survival of mycobacteria, including Mycobacterium tuberculosis that causes TB. The results were published in the journal Antimicrobial Agents and Chemotherapy. Unlike most antibiotics that target the bacterial metabolism by aiming at the cellular components, the... Continue Reading →

Pharmacies in India may not be causing TB drug-resistance

If an earlier study revealed the tendency of private practitioners to liberally use antibiotics to treat tuberculosis leading to a delay in TB diagnosis and treatment and increase the chances of TB spreading within a community, pharmacies in Delhi, Mumbai and Patna are no better. A study published on August 25, 2016 in the journal... Continue Reading →

A novel, powerful antibiotic found inside human nose

A novel antibiotic — lugdunin — produced by a bacterium found inside the human nose has been found to kill the bacterium Staphylococcus aureus, including drug-resistant forms such as the methicillin-resistant S. aureus (MRSA). The study found S. aureus does not develop resistance against the novel antibiotic. The findings could aid the development of new... Continue Reading →

Will mcr-1 gene cause a new superbug?

Alarm bells have been sounded after a woman in the U.S. was detected with bacteria resistant to a last-resort antibiotic. The 49-year-old was carrying E. coli bearing a new gene, mcr-1, which is resistant to colistin, the last available antibiotic that works against strains that have acquired protection against all other medication. This is the... Continue Reading →

Create a website or blog at WordPress.com

Up ↑

%d bloggers like this: